drugset / Trial / NCT07580716
Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
Phase 2
Recruiting
270 enrolled
Enlivex Therapeutics Ltd.
Nordic Bioscience Clinical Development (NBCD) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, Phase IIb study to evaluate intra-articular (IA) injections of Allocetra in participants with moderate-to-severe age related symptomatic primary knee osteoarthritis (OA).
Timeline
- Start
- 2026-05-01
- Primary completion
- 2027-02
- Completion
- 2028-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allocetra | Cell therapy | — | Other |